Terms: = Kidney tumors AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
54 results:
1. MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via erk-AP1-MMPs axis.
Wei H; Li Y; Zhang J; Xu C; Wei D; Quan C; Zhu S
Sci Rep; 2024 Apr; 14(1):9411. PubMed ID: 38658579
[TBL] [Abstract] [Full Text] [Related]
2. The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Gu Y; Huang Q; Wang Y; Wang H; Xiang Z; Xu Y; Wang X; Liu W; Wang A
BMC Cancer; 2024 Apr; 24(1):420. PubMed ID: 38580922
[TBL] [Abstract] [Full Text] [Related]
3. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract] [Full Text] [Related]
4. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
5. The single-cell evolution trajectory presented different hypoxia heterogeneity to reveal the carcinogenesis of genes in clear cell renal cell carcinoma: Based on multiple omics and real experimental verification.
Ma B; Qin L; Sun Z; Wang J; Tran LJ; Zhang J; Ye F; Liu Y; Chen M
Environ Toxicol; 2024 Feb; 39(2):869-881. PubMed ID: 37886854
[TBL] [Abstract] [Full Text] [Related]
6. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
7. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
[TBL] [Abstract] [Full Text] [Related]
8. The Effect of CacyBP/SIP on the Phosphorylation of erk1/2 and p38 Kinases in Clear Cell Renal Cell Carcinoma.
Smereczańska M; Domian N; Młynarczyk G; Kasacka I
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373509
[TBL] [Abstract] [Full Text] [Related]
9. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
10. HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis.
Yin L; Li W; Chen X; Wang R; Zhang T; Meng J; Li Z; Xu L; Yin R; Cheng B; Yang H
Adv Sci (Weinh); 2023 Jun; 10(17):e2206955. PubMed ID: 37085921
[TBL] [Abstract] [Full Text] [Related]
11. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and erk2 and inhibiting erk2 phosphorylation.
Yang W; Zhang Z; Li L; Zhang K; Xu Y; Xia M; Zhou J; Gong Y; Chen J; Gong K
Cell Death Dis; 2023 Mar; 14(3):212. PubMed ID: 36966163
[TBL] [Abstract] [Full Text] [Related]
12. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
13. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/erk signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract] [Full Text] [Related]
14. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract] [Full Text] [Related]
15. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
[TBL] [Abstract] [Full Text] [Related]
16. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through erk/AKT Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract] [Full Text] [Related]
17. Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21-5p/TGFBR2/p38/EGR1 Axis.
Wang C; Xu H; Liao X; Wang W; Wu W; Li W; Niu L; Li Z; Li A; Sun Y; Huang W; Song F
Mol Cancer Res; 2023 Jan; 21(1):62-75. PubMed ID: 36125433
[TBL] [Abstract] [Full Text] [Related]
18. Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Santoni M; Monteiro FSM; Massari F; Abahssain H; Aurilio G; Molina-Cerrillo J; Myint ZW; Zabalza IO; Battelli N; Grande E
Crit Rev Oncol Hematol; 2022 Aug; 176():103731. PubMed ID: 35718065
[TBL] [Abstract] [Full Text] [Related]
19. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract] [Full Text] [Related]
20. TOPK/PBK is phosphorylated by erk2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
Sun H; Zheng J; Xiao J; Yue J; Shi Z; Xuan Z; Chen C; Zhao Y; Tang W; Ye S; Li J; Deng Q; Zhang L; Zhu F; Shao C
Cell Death Dis; 2022 May; 13(5):450. PubMed ID: 35546143
[TBL] [Abstract] [Full Text] [Related]
[Next]